Galderma Group AG
GALD | SW
Overview
Corporate Details
- ISIN(s):
- CH1335392721
- LEI:
- 89450001OK6O8ELQ4584
- Country:
- Switzerland
- Address:
- Zählerweg 10, 6300 Zug
- Website:
- https://www.galderma.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Galderma Group AG is a global leader in dermatology, dedicated to enhancing the quality of life by providing innovative medical solutions for the skin, hair, and nails. Founded in 1981, Galderma has grown to become a trusted partner in dermatology, offering a comprehensive portfolio of prescription medicines, aesthetics solutions, and consumer care products. Galderma's mission is to meet the needs of dermatology patients and practitioners by developing and marketing advanced therapeutic solutions. The company's research and development efforts are focused on addressing a wide range of dermatological conditions, including acne, rosacea, psoriasis, and skin cancer, as well as providing solutions for skin rejuvenation and protection.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-31 | N/A | Non-Executive member | Sell | None | 935,664.75 CHF |
| 2025-03-28 | N/A | Non-Executive member | Sell | None | 1,876,958.07 CHF |
| 2025-03-27 | N/A | Non-Executive member | Sell | None | 265,440.84 CHF |
| 2025-03-26 | N/A | Non-Executive member | Sell | None | 673,175.70 CHF |
| 2025-03-25 | N/A | Executive member | Buy | None | 243,205.38 CHF |
| 2025-03-20 | N/A | Non-Executive member | Sell | None | 1,156,106.24 CHF |
| 2025-03-20 | N/A | Non-Executive member | Sell | None | 47,702.12 CHF |
| 2025-03-17 | N/A | Executive member | Sell | None | 7,962,599.99 CHF |
| 2024-12-20 | N/A | Non-Executive member | Sell | None | 105,831.00 CHF |
| 2024-11-06 | N/A | Non-Executive member | Sell | None | 177,500.00 CHF |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Valneva SE | France | VLA | |
|
VENTURE LIFE GROUP PLC | United Kingdom | VLG | |
|
Vetoquinol SA | France | VETO | |
|
Vicore Pharma Holding | Sweden | VICO | |
|
Vifor Pharma AG | Switzerland | VIFN | |
|
Vimian Group AB | Sweden | VIMIAN | |
|
Virbac | France | FR000 | |
|
Vistin Pharma | Norway | VISTN | |
|
Vivesto | Sweden | VIVE | |
|
Xlife Sciences AG | Switzerland | XLS |